These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26897538)

  • 1. Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria.
    Ma L; Wang Y; Wang M; Tian Y; Kang W; Liu H; Wang H; Dou J; Zhou C
    Biomaterials; 2016 May; 87():32-45. PubMed ID: 26897538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
    Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
    J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids.
    Kang W; Liu H; Ma L; Wang M; Wei S; Sun P; Jiang M; Guo M; Zhou C; Dou J
    Eur J Pharm Sci; 2017 Jul; 105():169-177. PubMed ID: 28522372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
    Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
    Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activities of peptide Cbf-K
    Jiang M; Ma L; Huang Y; Wu H; Dou J; Zhou C
    Microb Pathog; 2020 Jan; 138():103847. PubMed ID: 31704464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo.
    Jiang M; Yang X; Wu H; Huang Y; Dou J; Zhou C; Ma L
    Biochem Pharmacol; 2020 Feb; 172():113746. PubMed ID: 31812678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cbf-14, a cationic peptide derived from cathelin-domain, exhibits anti-inflammation activity via inhibiting PI3K- Akt /ROS/ NF-κB signaling pathway.
    Xie X; He L; Wang Y; Ye X; Ma L
    Peptides; 2023 Aug; 166():171040. PubMed ID: 37295650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
    Lee JK; Seo CH; Luchian T; Park Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing potent antimicrobial peptides by disulphide linked dimerization and N-terminal lipidation to increase antimicrobial activity and membrane perturbation: Structural insights into lipopolysaccharide binding.
    Datta A; Kundu P; Bhunia A
    J Colloid Interface Sci; 2016 Jan; 461():335-345. PubMed ID: 26407061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles.
    Chen C; Chen Y; Yang C; Zeng P; Xu H; Pan F; Lu JR
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17346-55. PubMed ID: 26204061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity.
    Kim YM; Kim NH; Lee JW; Jang JS; Park YH; Park SC; Jang MK
    Biochem Biophys Res Commun; 2015 Jul; 463(3):322-8. PubMed ID: 26028561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane active antimicrobial activity and molecular dynamics study of a novel cationic antimicrobial peptide polybia-MPI, from the venom of Polybia paulista.
    Wang K; Yan J; Dang W; Liu X; Chen R; Zhang J; Zhang B; Zhang W; Kai M; Yan W; Yang Z; Xie J; Wang R
    Peptides; 2013 Jan; 39():80-8. PubMed ID: 23159560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
    Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
    Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
    Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
    J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
    Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
    FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
    Eley A; Ibrahim M; Kurdi SE; Conlon JM
    Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity.
    Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y
    Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.
    Aghazadeh H; Memariani H; Ranjbar R; Pooshang Bagheri K
    Chem Biol Drug Des; 2019 Jan; 93(1):75-83. PubMed ID: 30120878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane interaction and antibacterial properties of chensinin-1, an antimicrobial peptide with atypical structural features from the skin of Rana chensinensis.
    Shang D; Sun Y; Wang C; Wei S; Ma L; Sun L
    Appl Microbiol Biotechnol; 2012 Dec; 96(6):1551-60. PubMed ID: 22581068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.
    Zhang Q; Xu Y; Wang Q; Hang B; Sun Y; Wei X; Hu J
    Antimicrob Agents Chemother; 2015 May; 59(5):2835-41. PubMed ID: 25753638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.